| Aug 22, 2024 |
Aug 26, 2024 |
Inhibrx Biosciences, Inc.
|
Director |
Buy |
100.0
|
+75,000
|
50.15%
|
✗
|
$1M |
| Aug 11, 2020 |
Aug 13, 2020 |
Virtus Equity & Convertible Income Fund
|
Other |
Sell |
20.0
|
-20,000
|
-100.00%
|
✗
|
$493.3K |
| Jun 25, 2014 |
Jun 27, 2014 |
Virtus Convertible & Income Fund
|
Other |
Sell |
22.5
|
-15,000
|
-100.00%
|
✗
|
$158.7K |
| Aug 15, 2007 |
Jan 29, 2009 |
Virtus Convertible & Income Fund
|
Other |
Buy |
95.0
|
+4,300
|
40.19%
|
✗
|
$51.4K |
| Sep 18, 2008 |
Sep 22, 2008 |
Virtus Equity & Convertible Income Fund
|
Other |
Buy |
87.5
|
+10,000
|
3.07%
|
✗
|
$150.9K |
| Aug 17, 2007 |
Aug 21, 2007 |
Virtus Equity & Convertible Income Fund
|
Other |
Buy |
95.0
|
+5,000
|
100.00%
|
✗
|
$107.9K |
| Aug 16, 2007 |
Aug 17, 2007 |
Virtus Equity & Convertible Income Fund
|
Other |
Buy |
95.0
|
+5,000
|
100.00%
|
✗
|
$97.9K |
| Aug 15, 2007 |
Aug 17, 2007 |
Virtus Convertible & Income Fund
|
Other |
Buy |
95.0
|
+15,000
|
100.00%
|
✗
|
$177.4K |